MC

524.9

-0.15%↓

SANES

10.228

-2.2%↓

BBVA

19.86

-1.97%↓

BNP

90.82

-1.86%↓

CABK

10.49

-2.15%↓

MC

524.9

-0.15%↓

SANES

10.228

-2.2%↓

BBVA

19.86

-1.97%↓

BNP

90.82

-1.86%↓

CABK

10.49

-2.15%↓

MC

524.9

-0.15%↓

SANES

10.228

-2.2%↓

BBVA

19.86

-1.97%↓

BNP

90.82

-1.86%↓

CABK

10.49

-2.15%↓

MC

524.9

-0.15%↓

SANES

10.228

-2.2%↓

BBVA

19.86

-1.97%↓

BNP

90.82

-1.86%↓

CABK

10.49

-2.15%↓

MC

524.9

-0.15%↓

SANES

10.228

-2.2%↓

BBVA

19.86

-1.97%↓

BNP

90.82

-1.86%↓

CABK

10.49

-2.15%↓

Search

Gimv NV

Slēgts

SektorsFinanšu

44.7 -0.89

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

44.3

Max

45.1

Galvenie mērījumi

By Trading Economics

Ienākumi

127M

Pārdošana

-49M

65M

P/E

Sektora vidējais

7.709

26.803

EPS

3.4

Dividenžu ienesīgums

5.91

Peļņas marža

195.239

Darbinieki

94

EBITDA

52M

128M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

5.91%

4.24%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

53M

1.7B

Iepriekšējā atvēršanas cena

45.59

Iepriekšējā slēgšanas cena

44.7

Ziņu noskaņojums

By Acuity

50%

50%

166 / 444 Rangs Finance

Gimv NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 11. febr. 23:47 UTC

Karstas akcijas

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

2026. g. 11. febr. 22:59 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Grab Holdings to Buy U.S.-Based Stash Financial

2026. g. 11. febr. 23:54 UTC

Peļņas

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

2026. g. 11. febr. 23:50 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 11. febr. 23:50 UTC

Tirgus saruna

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

2026. g. 11. febr. 23:49 UTC

Peļņas

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

2026. g. 11. febr. 23:45 UTC

Peļņas

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

2026. g. 11. febr. 23:42 UTC

Peļņas

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

2026. g. 11. febr. 23:41 UTC

Peļņas

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

2026. g. 11. febr. 23:40 UTC

Peļņas

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

2026. g. 11. febr. 23:35 UTC

Tirgus saruna

Gold Falls on Prospects of Long Fed Pause -- Market Talk

2026. g. 11. febr. 23:18 UTC

Tirgus saruna

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

2026. g. 11. febr. 23:14 UTC

Tirgus saruna

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

2026. g. 11. febr. 22:59 UTC

Peļņas

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

2026. g. 11. febr. 22:59 UTC

Peļņas

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

2026. g. 11. febr. 22:59 UTC

Peļņas

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

2026. g. 11. febr. 22:58 UTC

Peļņas

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

2026. g. 11. febr. 22:57 UTC

Peļņas

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

2026. g. 11. febr. 22:54 UTC

Peļņas

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

2026. g. 11. febr. 22:53 UTC

Peļņas

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

2026. g. 11. febr. 22:47 UTC

Peļņas

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

2026. g. 11. febr. 22:47 UTC

Peļņas

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

2026. g. 11. febr. 22:23 UTC

Peļņas

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

2026. g. 11. febr. 22:22 UTC

Peļņas

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

2026. g. 11. febr. 22:22 UTC

Peļņas

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

2026. g. 11. febr. 22:19 UTC

Peļņas

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

2026. g. 11. febr. 22:18 UTC

Peļņas

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

2026. g. 11. febr. 22:18 UTC

Peļņas

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

2026. g. 11. febr. 22:18 UTC

Peļņas

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

2026. g. 11. febr. 22:16 UTC

Peļņas

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Salīdzinājums

Cenas izmaiņa

Gimv NV Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Noskaņojums

By Acuity

166 / 444 Rangs Finanšu

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat